updating data for batch codes

docs/SymptomsCausedByDrugs/data/ProportionalReportingRatios/vaccines/39.json

@@ -1 +1 @@
-{"abdominal distension": 2.55, "abnormal dreams": 2.16, "abortion spontaneous": 2.1, "accidental exposure to product": 20.74, "alopecia": 8.9, "anuria": 3.07, "aphasia": 2.59, "arteriospasm coronary": 5.94, "aura": 28.75, "autoimmune thyroiditis": 2.48, "blepharospasm": 13.54, "brain fog": 3.49, "cluster headache": 4.07, "colitis ischaemic": 3.46, "concussion": 8.6, "constipation": 22.7, "coronavirus infection": 3.81, "craniocerebral injury": 6.76, "depression": 2.06, "device defective": 8.98, "device delivery system issue": 4.26, "device difficult to use": 197.67, "device issue": 18.26, "device leakage": 5.24, "device malfunction": 5.61, "device use error": 12.83, "drug dose omission by device": 83.27, "drug ineffective": 2.25, "drug ineffective for unapproved indication": 3.99, "drug intolerance": 4.19, "dyschezia": 7.92, "dyspepsia": 2.57, "faecaloma": 8.28, "faeces hard": 10.13, "flatulence": 2.41, "gastrointestinal motility disorder": 8.36, "gastrooesophageal reflux disease": 2.46, "ileus": 2.56, "ileus paralytic": 3.04, "impaired gastric emptying": 6.94, "incorrect disposal of product": 147.53, "incorrect dose administered": 2.08, "incorrect dose administered by device": 12.21, "incorrect route of product administration": 4.77, "initial insomnia": 2.32, "injection site bruising": 4.8, "injection site extravasation": 9.27, "injection site haemorrhage": 12.79, "injection site hypersensitivity": 4.98, "injection site pruritus": 2.3, "injection site rash": 6.87, "injection site urticaria": 8.93, "intestinal obstruction": 5.24, "irritable bowel syndrome": 3.23, "joint stiffness": 2.11, "mastoiditis": 31.71, "maternal exposure during pregcy": 2.55, "medication overuse headache": 29.86, "memory impairment": 2.7, "middle insomnia": 3.09, "migraine": 26.02, "migraine with aura": 9.96, "muscle spasms": 3.52, "muscle tightness": 2.44, "muscle twitching": 2.2, "neck pain": 2.01, "needle issue": 10.67, "neovascularisation": 106.92, "nephrolithiasis": 2.39, "normal newborn": 5.45, "panic attack": 2.43, "paradoxical drug reaction": 11.97, "poor quality sleep": 3.81, "product communication issue": 26.46, "product storage error": 8.08, "raynaud's phenomenon": 11.24, "rib fracture": 2.14, "rubber sensitivity": 31.95, "sleep disorder": 2.7, "status migrainosus": 57.58, "stress": 3.28, "syringe issue": 6.0, "tension headache": 5.43, "therapeutic product effect decreased": 7.26, "therapeutic product effect incomplete": 5.78, "therapeutic response shortened": 23.53, "therapy non-responder": 2.12, "tinnitus": 2.34, "toothache": 2.15, "trigeminal neuralgia": 2.81, "vascular malformation": 44.03, "weight increased": 3.86, "wrist fracture": 2.52, "wrong technique in device usage process": 3.92, "wrong technique in product usage process": 9.19}
+{"abdominal distension": 3.39, "abnormal dreams": 3.05, "accidental exposure to product": 50.89, "acne": 2.19, "adverse event": 2.01, "alopecia": 9.52, "application site erythema": 2.82, "brain fog": 2.3, "constipation": 10.67, "depressed mood": 2.29, "device delivery system issue": 39.53, "device difficult to use": 21.31, "device issue": 7.86, "device leakage": 36.97, "device malfunction": 17.32, "drug dose omission by device": 57.74, "drug hypersensitivity": 2.72, "dry eye": 3.92, "dry mouth": 2.41, "dry skin": 2.05, "flatulence": 4.26, "hypersensitivity": 2.64, "inappropriate schedule of product administration": 2.76, "incorrect dose administered": 3.32, "incorrect dose administered by device": 20.51, "initial insomnia": 5.24, "injection site bruising": 8.46, "injection site discharge": 34.31, "injection site discolouration": 21.67, "injection site erythema": 10.29, "injection site extravasation": 13.4, "injection site haemorrhage": 7.69, "injection site hypersensitivity": 33.67, "injection site induration": 9.65, "injection site mass": 10.67, "injection site oedema": 19.37, "injection site pruritus": 21.8, "injection site rash": 41.39, "injection site reaction": 4.38, "injection site swelling": 5.0, "injection site urticaria": 23.77, "injection site vesicles": 21.39, "injection site warmth": 2.45, "insomnia": 2.06, "maternal exposure during pregnancy": 2.5, "migraine": 7.13, "migraine with aura": 5.9, "needle issue": 16.24, "panic attack": 3.66, "poor quality sleep": 4.72, "pruritus": 2.73, "raynaud's phenomenon": 14.08, "skin reaction": 3.64, "therapeutic product effect decreased": 3.99, "therapeutic product effect incomplete": 2.03, "therapeutic response shortened": 14.16, "throat tightness": 2.73, "weight increased": 7.53, "wrong technique in product usage process": 2.22}